Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy.

Published

Journal Article (Review)

Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of neoplasms derived from peptide- and amine-secreting cells of the neuroendocrine system. NENs commonly arise in the GI tract but can arise in most organs of the body. NENs in different organs share many common pathologic features. Although the incidence of NENs is not high, the prevalence is not low because many patients may live relatively long periods without major symptoms from the disease. While many of these tumors lead an indolent clinical course, they constitute a therapeutic challenge when they progress, metastasize and become symptomatic. Treatment requires a multidisciplinary approach including cytotoxic chemotherapy. Almost all clinical trials investigating cytotoxic chemotherapy in NENs are small single-arm studies and guidelines are derived from expert opinion and from extrapolating results from small cell lung cancer studies. This article briefly reviews NENs before focusing on reviewing data on the role of cytotoxic chemotherapy studies in NENs.

Full Text

Duke Authors

Cited Authors

  • Khasraw, M; Yap, SY; Ananda, S

Published Date

  • April 2013

Published In

Volume / Issue

  • 13 / 4

Start / End Page

  • 451 - 459

PubMed ID

  • 23560839

Pubmed Central ID

  • 23560839

Electronic International Standard Serial Number (EISSN)

  • 1744-8328

Digital Object Identifier (DOI)

  • 10.1586/era.13.22

Language

  • eng

Conference Location

  • England